BRD4 and cancer: In line with this, the anti-cancer activities (inhibition of growth, apoptosis) of BRD4 inhibitors have been shown to rely, at least in part, on transcriptional induction of the HEXIM1 gene, which allows recapture of P-TEFb into the 7SK inhibitory complex [294, 295].